|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Human medicine
|
|
Name of medicinal product:
|
ACIC 400 MG
|
|
Active substances:
|
|
|
ATC code:
|
J05AB01
|
|
Dosage form:
|
tablet
|
|
Strength:
|
400mg
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
 (last updated December 8, 2020)
|
|
Package information leaflet (PIL):
|
EST (last updated December 8, 2020)
|
|
Labelling:
|
(last updated October 29, 2020)
|
|
Indication:
|
Herpes simplex and Varicella zoster viral infection.
|
|
Safety features:
|
Yes
|
|
Marketing authorization holder:
|
Sandoz Pharmaceuticals d.d.
|
|
Marketing authorization number:
|
474705
|
|
Marketing authorization issued on:
|
June 17, 2005
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
|
Assessment report:
|
|
|
Description
|
Additional condition
|
|
Hambaarstil on õigus välja kirjutada
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1165384
|
ACIC 400 MG
|
tablet
|
400mg 35TK
|
Prescription
|
100% 50%
|
18,10
|
24.11.2023
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere